Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

SeptRx reports first 20 patients have been enrolled in its “InterSEPT” CE Mark trial of the SeptRx Intrapocket PFO Occluder

January 4, 2012 By AxoGen, Inc.

FREMONT, Calif.–(BUSINESS
WIRE
)–SeptRx, an emerging medical device company that has
developed the SeptRx® Intrapocket PFO Occluder (IPO) – a platform for the
percutaneous transcatheter closure of a heart defect known as patent foramen
ovale (PFO) – reported today that it has completed enrollment of the first 20
patients in its ongoing “InterSEPT” (In-tunnel SeptRx European PFO Trial)
clinical trial at Sankt Katharinen Hospital (Frankfurt, Germany) under
principal investigator Horst E. Sievert, M.D., and at Hôpital Privé Jacques
Cartier (Massy, France) under Jean-François Piéchaud, M.D.

InterSEPT data will be used to apply for CE marking for the
SeptRx® IPO. The SeptRx® IPO has previously completed a successful 11-patient
first-in-human (FIH) clinical trial. SeptRxs FIH trial was the first and only
PFO device trial to demonstrate 100% closure and 100% safety (out to 3 years).

“We are very pleased with the strong start to our InterSEPT
clinical trial,” said Scott Russell, CEO. “Early results look very encouraging,
building on the excellent patient outcomes from our first-in-human study. In
the coming months we will be expanding our trial into additional centers and
introducing our larger, 19-mm device into the trial. When the InterSEPT study
is completed, we will use the results to seek CE mark and commence marketing
and sales efforts in Europe.”

PFO is a tunnel-like defect connecting the right atrium with
the left atrium. A remnant of fetal circulation, it usually seals itself within
a few months after birth. Unfortunately, in about 25% of the population the PFO
does not fully close and may allow blood (and emboli) to pass directly between
the right and left atria. The presence of a PFO has been identified as a
contributing factor in cryptogenic stroke, chronic migraine, decompression
sickness, and obstructive sleep apnea. A PFO contributes to these conditions by
providing a pathway for emboli (blood clots, air bubbles) in the venous system
to reach the arterial system by passing directly from the right atrium to the
left.

SeptRx, Inc. is an emerging medical device company that has
developed the SeptRx® Intrapocket PFO Occluder (IPO), a platform for the
percutaneous transcatheter closure of a heart defect known as patent foramen
ovale (PFO).

NOTICE: The SeptRx® IPO is not approved for sale in any
regulatory jurisdiction. Further, it is not yet available for investigational
use or commercial sale in the U.S.

Posted by Sean Fenske, Editor-in-Chief, MDT

Related Articles Read More >

Dexcom One
How Dexcom’s portfolio goes beyond highly-anticipated next-gen G7
A portrait of Stryker executive Siddarth Satish
How Stryker includes users for product design in the digital age
A Medtronic HVAD pump opened up to show the inner workings
Medtronic investigates HVAD pump welds after patient deaths
Galien Foundation 2022 nominees
18 of the world’s most innovative medical technologies

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech